As shown in Figure 2A, the serum ITGB4 concentration of 1.624 ng/mL in CRC patients (Q25–Q75: 0.763–2.261 ng/mL) was significantly higher than that in non‐CRC participants (0.638 ng/mL, Q25–Q75: 0.246–1.206 ng/mL, p < 0.05). The gene discussed is ITGB4; the disease is colorectal carcinoma.